Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Physiology. Regulatory Integrative and Comparative Physiology

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPREGU.2001.280.3.R605PMID 11171636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amylin: a novel action in the brain to reduce body weight.

  2000cited by this paper
• Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats.

  2000cited by this paper
• Amylin and insulin interact to reduce food intake in rats.

  2000cited by this paper
• I. Sensing of lipid by the intestinal mucosa.

  1999cited by this paper
• Behaviorally specific inhibition of sham feeding by amylin.

  1998cited by this paper
• The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM

  1998cited by this paper
• Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.

  1998cited by this paper
• Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).

  1998cited by this paper
• Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats.

  1998influential reference
• Hypoglycemia Overrides Amylin-Mediated Regulation of Gastric Emptying in Rats

  1998cited by this paper
• Synergy between amylin and cholecystokinin for inhibition of food intake in mice.

  1998cited by this paper
• Adrenomedullin, amylin, calcitonin gene-related peptide and their fragments are potent inhibitors of gastric acid secretion in rats.

  1997cited by this paper
• Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects.

  1997cited by this paper
• Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

  1997cited by this paper
• Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat

  1996cited by this paper
• Chronic infusion of islet amyloid polypeptide causes anorexia in rats.

  1996cited by this paper
• Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.

  1996cited by this paper
• Leptin enters the brain by a saturable system independent of insulin.

  1996cited by this paper
• Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake.

  1996cited by this paper
• Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin

  1995cited by this paper
• Islet amyloid polypeptide (amylin) is expressed in sensory neurons

  1995cited by this paper
• Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats.

  1995cited by this paper
• Permeability of the blood-brain barrier to amylin.

  1995cited by this paper
• In vitro autoradiographic localization of amylin binding sites in rat brain.

  1994cited by this paper
• Cholecystokinin and control of food intake.

  1994cited by this paper
• Amylin given by central and peripheral routes inhibits acid gastric secretion.

  1994cited by this paper
• Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse.

  1994cited by this paper
• Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats.

  1994cited by this paper
• Anorexia following the intrahypothalamic administration of amylin.

  1991cited by this paper
• Analysis and comparison of sigmoidal curves: application to dose-response data.

  1989cited by this paper
• Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

  1987cited by this paper
• Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.

  1987cited by this paper
• A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

  1986cited by this paper
• Comparative effects of CCK-8 on feeding, sham feeding, and exocrine pancreatic secretion in rats.

  1986cited by this paper
• Effect of nutrient density and composition of liquid meals on gastric emptying in feeding rats.

  1983cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper

• The story of amylin: from physiology to therapy

  2026cites this paper
• Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice

  2025cites this paper
• Role of amylin in feeding and satiation.

  2025cites this paper
• Amylin‐like immunoreactivity in the extra‐islet peptide YY‐producing and glucagon‐immunoreactive cells in Japanese quail pancreas

  2024cites this paper
• Current Status of Therapeutic Peptides for the Management of Diabetes Mellitus

  2024cites this paper
• Oxytocin increased intragastric pressure in the forestomach of rats via the dorsal vagal complex.

  2023cites this paper
• Rosiglitazone protects INS-1E cells from human islet amyloid polypeptide toxicity.

  2022cites this paper
• Derivatization with fatty acids in peptide and protein drug discovery

  2022cites this paper
• Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake.

  2021cites this paper
• A selective role for receptor activity‐modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice

  2021cites this paper
• Islet amyloid toxicity: From genesis to counteracting mechanisms

  2021cites this paper
• Impact of Gut and Metabolic Hormones on Feeding Reward.

  2021cites this paper
• Development of Cagrilintide, a Long-Acting Amylin Analogue.

  2021cites this paper
• Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases.

  2020cites this paper
• L-glutamate stimulates cholecystokinin secretion via the T1R1/T1R3 mediated PLC/TRPM5 transduction pathway.

  2020cites this paper
• Salmon calcitonin distributes into the arcuate nucleus in mice to a subset of NPY neurons.

  2020cites this paper
• Efficacy and mechanism of action of long-term treatment with antibody NI-203.26C11 targeting aggregated IAPP in type 2 diabetes

  2020cites this paper
• Amylin brain circuitry.

  2020cites this paper
• Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism.

  2020cites this paper
• Human Amylin: From Pathology to Physiology and Pharmacology.

  2019cites this paper
• Does modulation of amylin’s second messenger system influence its anorectic effect?

  2018cites this paper
• Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity

  2018cites this paper
• Dysfunctional oleoylethanolamide signaling in a mouse model of Prader‐Willi syndrome

  2017cites this paper
• Measurement of Pro-Islet Amyloid Polypeptide (1–48) in Diabetes and Islet Transplants

  2017cites this paper
• Title Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome Permalink

  2017cites this paper
• Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'- carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide

  2017cites this paper
• Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.

  2016cites this paper
• Amylin-mediated control of glycemia, energy balance, and cognition.

  2016cites this paper
• Development of shRNA screens to identify effectors of three complex traits : neighbour suppression of tumour growth and proliferation and protection from lipotoxicity in β-cells

  2016cites this paper
• Effects of solid‐phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet‐induced obese rats

  2016cites this paper
• Impaired pro-islet amyloid polypeptide processing promotes beta-cell dysfunction in diabetes and islet transplants

  2016cites this paper
• Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.

  2015cites this paper
• KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration.

  2015cites this paper
• Amylin: Pharmacology, Physiology, and Clinical Potential

  2015cites this paper
• Islet amyloid polypeptide exerts a novel autocrine action in β‐cell signaling and proliferation

  2015cites this paper
• The Effect of Whey Protein on Short-term Food Intake and Post-meal Glycemic Regulation in Young Adults

  2014cites this paper
• Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.

  2014cites this paper
• Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults.

  2014cites this paper
• Cyclic N-terminal loop of amylin forms non amyloid fibers.

  2013cites this paper
• Interactions driving the collapse of islet amyloid polypeptide: implications for amyloid aggregation

  2013cites this paper
• Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats.

  2013cites this paper
• The interaction of amylin with other hormones in the control of eating

  2013cites this paper
• Islet amyloid polypeptide and diabetes.

  2013cites this paper
• Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats.

  2012cites this paper
• Experimental models for investigating IAPP regulation of food intake in rats and mice

  2012cites this paper
• Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP

  2012cites this paper
• Pancreatic beta cells turnover: effects of endogenous hyperinsulinemia and amyloid deposits

  2012cites this paper
• Pramlintide in the Treatment of Diabetes Mellitus

  2012cites this paper
• The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval.

  2011cites this paper
• CHAPTER 35 – Neuroendocrine Control of Energy Stores

  2011cites this paper
• Control of energy homeostasis by amylin

  2011cites this paper
• Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

  2011cites this paper
• Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

  2011cites this paper
• Fat-Rich Food Palatability and Appetite Regulation

  2010cites this paper
• Effects of Various Doses of Cholecystokinin Octapeptide and Cerulein on Antral Slow-Wave Frequency and Amplitude in Conscious Sheep

  2008cites this paper
• Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.

  2008cites this paper
• Central and peripheral administration of amylin induces energy expenditure in anesthetized rats.

  2008cites this paper
• Low‐dose Pramlintide Reduced Food Intake and Meal Duration in Healthy, Normal‐Weight Subjects

  2007cites this paper
• Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats.

  2007influential citation
• Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat.

  2007cites this paper
• Brainstem-hypothalamic neuropeptides and the regulation of feeding

  2007cites this paper
• Amylin in the Periphery II: An Updated Mini-Review

  2006cites this paper
• Ghrelin Attenuates the Inhibitory Effects of Glucagon-Like Peptide-1 and Peptide YY(3-36) on Food Intake and Gastric Emptying in Rats

  2006cites this paper
• Role of Amylin and Calcitonin-Gene-Related Peptide (CGRP) in the Control of Food Intake

  2006cites this paper
• Pharmacological Characterization of Hydrolysis-Resistant Analogs of Oleoylethanolamide with Potent Anorexiant Properties

  2006cites this paper
• Body Weight Regulation and Hypothalamic Neuropeptides

  2006cites this paper
• Inhibition of food intake.

  2005cites this paper
• Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats.

  2005cites this paper
• Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

  2005cites this paper
• Pancreatic amylin as a centrally acting satiating hormone.

  2005cites this paper
• Chronically Administered Islet Amyloid Polypeptide in Rats Serves as an Adiposity Inhibitor and Regulates Energy Homeostasis

  2005cites this paper
• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

  2005cites this paper
• Use of a real-time polymerase chain reaction-based fluorogenic 5' nuclease assay to evaluate insect vectors of Corynebacterium pseudotuberculosis infections in horses.

  2004cites this paper
• Effects of feeding large amounts of grain on colonic contents and feces in horses.

  2004cites this paper
• Food intake and ageing--the role of the gut.

  2004cites this paper
• Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats.

  2004cites this paper
• Amylin receptor blockade stimulates food intake in rats.

  2004influential citation
• Characterization of the fatty-acid amide hydrolase inhibitor URB 597 : Effects on anandamide and oleoylethanolamide deactivation

  2004cites this paper
• in focus Regulating food intake

  2003cites this paper
• Soybean beta-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats.

  2003cites this paper
• Central amylin signaling and the regulation of energy homeostasis.

  2003cites this paper
• Effects of peripheral CCK receptor blockade on gastric emptying in rats.

  2003cites this paper
• Regulation of amylin release from cultured rabbit gastric fundic mucosal cells

  2003cites this paper
• Effects of peripheral CCK receptor blockade on food intake in rats.

  2003cites this paper
• Islet Amyloid Polypeptide/GLP‐1/Exendin

  2003cites this paper
• The gut hormones and their roles in obesity and gastric restrictive surgery

  2003cites this paper
• Modulation of Meal Pattern in the Rat by the Anorexic Lipid Mediator Oleoylethanolamide

  2003cites this paper
• Gastric Emptying and Control of Ingestion in Preweanling Rat Pups

  2003cites this paper
• Regulating food intake.

  2003cites this paper
• Peptides that regulate food intake.

  2003cites this paper
• Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats.

  2003cites this paper
• Chapter 14 Role of the intestine in regulation of food intake in growing pigs

  2002cites this paper
• Molecular pharmacology of the calcitonin receptor.

  2002cites this paper
• Hydration of Colonic Ingesta and Feces in Horses Fed Large Grain Meals or Treated with Enteral Fluid Therapy, Saline Cathartics and Intravenous Fluid Therapy

  2002cites this paper
• Regulation of body weight.

  2002cites this paper
• Carbohydrate and satiety.

  2002cites this paper
• Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats.

  2002influential citation
• Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP.

  2001cites this paper
• Stem Cell-Based Therapy for Type 1 Diabetes

  year unknowncites this paper